Publication | Open Access
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
152
Citations
61
References
2017
Year
This clinical trial (LEISH1) was registered at EudraCT (2012-005596-14) and ISRCTN (07766359).
| Year | Citations | |
|---|---|---|
Page 1
Page 1